terça-feira, 13 de novembro de 2012

Valley surgeon heads up test of aneurysm treatment - Minneapolis / St. Paul Business Journal:

gault-rickettsias.blogspot.com
Rodriguez, the director of peripheral vascular services at the Arizona Heart Institute, has been named the national principal investigator for the Phase II which is required by the to enroll 160 The Arizona Heart Institute is one of 14 centers involvecd in the study nationwide. “We are lookingf to include at least six more centers to complet e 20 centers inthe U.S.,” Rodriguez said. The endoluminao graft is manufactured bynear Glasgow, Called the Anaconda Stent Grafrt System, it allows the surgeojn to reposition the device once it has been placeed across the aneurysm.
So far, nearly 4,000 patients in Europe have received theAnaconda device, but it must get approvapl from the FDA before it can be used in the U.S. Rodriguez said the minimally invasive procedure onthe study’s firs patient went well, saying the device is very easy to use. “Her was up on his feet the next morninghavinfg breakfast,” Rodriguez said of the “You can’t do that when you open the chest. This eliminateds the need for openheart surgery.” Abdominal aortic or “ballooning” of the body’s main artery, is a seriousw condition prone to rupture and lead to sudden Actor John Ritter died of an aortif rupture in 2003.
Symptoms can occud suddenly with severe, sharp pain in the abdomen. Patientws who experience these symptoms should seek immediatsemedical attention, Rodriguez said. Early detection can prevent suddeb death. Patients with a familu history of aortic aneurysm or other connectivew tissue disorders should notify their physician abou t their risk of aortic he said.

Nenhum comentário:

Postar um comentário